(qq) 19-nor-4-androstenediol (3beta, 17beta-dihydroxyestr-4-ene; 3alpha, 17beta-dihydroxyestr-4-ene);
(rr) 19-nor-5-androstenediol (3beta, 17beta-dihydroxyestr-5-ene; 3alpha, 17beta-dihydroxyestr-5-ene);
(ss) 19-nor-4,9(10)-androstadienedione;
(tt) 19-nor-4-androstenedione (estr-4-en-3,17-dione);
(uu) 19-nor-5-androstenedione (estr-5-en-3,17-dione);
(vv) Norbolethone;
(ww) Norclostebol;
(xx) Norethandrolone;
(yy) Normethandrolone
(zz) Oxandrolone;
(aaa) Oxymesterone;
(bbb) Oxymetholone;
(ccc) Prostanozol;
(ddd) Stanozolol;
(eee) Stenbolone;
(fff) Testolactone;
(ggg) Testosterone;
(hhh) Tetrahydrogestrinone;
(iii) Trenbolone.
This order shall become effective upon publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated _______________________
Doug Englebert, Chair
Controlled Substances Board